Patent · US Active

Poly(diaminosulfide) particle-based vaccine

US11904006B2 · kind B2 · utility

0Cited by
13References
20Claims
0Family size

Assignees

Inventors

Key dates

Filing dateDec 11, 2020
Grant dateFeb 20, 2024
Priority date
Expiry dateMar 16, 2041

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2039/6093
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A composition comprising particles formed of poly(diaminosulfide) and one or more leptospiral antigens, and methods of making and using the composition, are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.